An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in
Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 …

We developed a metagenomic next-generation sequencing (mNGS) test using cell-free DNA
from body fluids to identify pathogens. The performance of mNGS testing of 182 body fluids …

Given the limited availability of serological testing to date, the seroprevalence of SARS-CoV-2-specific
antibodies in different populations has remained unclear. Here, we report very …

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread globally, with >365,000 cases in California …

An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in
Wuhan, China in December 2019 and the COVID-19 disease associated with infection has …

Importance The period following heart failure hospitalization (HFH) is a vulnerable time with
high rates of death or recurrent HFH. Objective To evaluate clinical characteristics, outcomes…

Background Coronavirus disease 2019 (COVID-19) primarily affects the lungs, but evidence
of systemic disease with multi-organ involvement is emerging. Here, we developed a blood …

Background Because of inaccuracies in commonly used tests for food allergy, oral food
challenges (OFCs) are considered the criterion standard, but OFC implementation is suboptimal. …

Importance Cerebrospinal fluid (CSF) cytologic testing and flow cytometry are insensitive for
diagnosing neoplasms of the central nervous system (CNS). Such clinical phenotypes can …

Background Metagenomic next-generation sequencing (mNGS) of body fluids is an emerging
approach to identify occult pathogens in undiagnosed patients. We hypothesized that …